Dr. James Petre, MD

NPI: 1619973989
Total Payments
$226,128
2024 Payments
$12,304
Companies
61
Transactions
1,316
Medicare Patients
1,897
Medicare Billing
$224,186

Payment Breakdown by Category

Other$186,329 (82.4%)
Food & Beverage$21,678 (9.6%)
Travel$12,499 (5.5%)
Consulting$5,175 (2.3%)
Education$447.67 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $171,729 119 75.9%
Food and Beverage $21,678 1,085 9.6%
Honoraria $14,600 8 6.5%
Travel and Lodging $12,499 79 5.5%
Consulting Fee $5,175 1 2.3%
Education $447.67 24 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $61,451 200 $0 (2024)
Amgen Inc. $56,199 122 $0 (2024)
Regeneron Healthcare Solutions, Inc. $26,402 40 $0 (2019)
Janssen Pharmaceuticals, Inc $19,708 54 $0 (2024)
Orexigen Therapeutics, Inc. $16,518 29 $0 (2017)
IDORSIA PHARMACEUTICALS US INC $13,307 26 $0 (2024)
Regeneron Pharmaceuticals, Inc. $6,454 10 $0 (2018)
SANOFI-AVENTIS U.S. LLC $5,870 18 $0 (2022)
Esperion Therapeutics, Inc. $5,371 54 $0 (2021)
Allergan, Inc. $3,705 89 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,304 153 AstraZeneca Pharmaceuticals LP ($7,878)
2023 $16,356 124 IDORSIA PHARMACEUTICALS US INC ($11,295)
2022 $9,823 128 AstraZeneca Pharmaceuticals LP ($5,155)
2021 $19,325 175 AstraZeneca Pharmaceuticals LP ($6,364)
2020 $15,279 104 Amgen Inc. ($8,778)
2019 $52,874 212 Amgen Inc. ($34,752)
2018 $55,718 208 AstraZeneca Pharmaceuticals LP ($20,965)
2017 $44,449 212 Orexigen Therapeutics, Inc. ($16,518)

All Payment Transactions

1,316 individual payment records from CMS Open Payments — Page 1 of 53

Date Company Product Nature Form Amount Type
12/24/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.37 General
12/19/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.79 General
Category: Cardiovascular and Metabolism
12/13/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $7.96 General
Category: RESPIRATORY
12/12/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $23.39 General
Category: DIABETES
12/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $18.67 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/05/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $23.65 General
Category: Oncology
12/03/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $11.87 General
Category: IMMUNOLOGY
12/03/2024 ABBVIE INC. UBRELVY (Drug), SYNTHROID Food and Beverage In-kind items and services $9.39 General
Category: NEUROSCIENCE
11/26/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $20.98 General
Category: NEUROSCIENCE
11/26/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $6.00 General
Category: PAIN
11/25/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $26.23 General
Category: PSYCHIATRY
11/22/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $28.31 General
Category: Cardiology
11/20/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $14.30 General
Category: CNS
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.01 General
Category: NEUROSCIENCE
11/08/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $5.77 General
Category: NEUROSCIENCE
11/07/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.87 General
Category: Cardiology/Vascular Diseases
11/07/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $2.10 General
Category: ENDOCRINOLOGY
11/06/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $15.96 General
Category: PSYCHIATRY
11/05/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $21.95 General
11/05/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.58 General
Category: NEUROSCIENCE
10/31/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.42 General
Category: RESPIRATORY
10/31/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $11.02 General
Category: Diabetes
10/29/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $21.52 General
Category: Cardiovascular and Metabolism
10/24/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $15.61 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/22/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $19.23 General
Category: Cardiology/Vascular Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 460 714 $142,026 $60,854
2022 14 642 943 $161,015 $65,839
2021 7 397 679 $135,145 $56,295
2020 6 398 665 $120,765 $41,198
Total Patients
1,897
Total Services
3,001
Medicare Billing
$224,186
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 187 378 $73,491 $29,584 40.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 56 100 $26,500 $12,775 48.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 76 76 $20,900 $9,378 44.9%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 29 35 $13,125 $3,963 30.2%
90662 Influenza vaccine split virus, preservative free Office 2023 43 43 $3,440 $3,093 89.9%
G0008 Administration of influenza virus vaccine Office 2023 44 44 $1,540 $1,305 84.7%
17000 Destruction of precancer skin growth, 1 growth Office 2023 11 11 $1,762 $492.13 27.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 14 27 $1,268 $264.41 20.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 208 466 $90,760 $38,194 42.1%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 52 71 $26,625 $8,697 32.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 60 60 $16,500 $7,517 45.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 24 36 $9,430 $4,459 47.3%
90662 Influenza vaccine split virus, preservative free Office 2022 29 29 $2,175 $1,916 88.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 21 23 $2,990 $985.87 33.0%
G0008 Administration of influenza virus vaccine Office 2022 35 35 $1,225 $980.22 80.0%
17000 Destruction of precancer skin growth, 1 growth Office 2022 17 17 $2,890 $770.79 26.7%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2022 11 12 $780.00 $604.92 77.6%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2022 42 42 $2,856 $557.55 19.5%
80053 Blood test, comprehensive group of blood chemicals Office 2022 45 46 $1,984 $481.27 24.3%
83036 Hemoglobin a1c level Office 2022 26 26 $780.00 $250.08 32.1%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2022 13 14 $700.00 $232.82 33.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 59 66 $1,320 $193.29 14.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 206 445 $86,775 $35,337 40.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 59 83 $21,165 $11,080 52.4%
17004 Destruction of 15 or more premalignant skin growths Office 2021 33 42 $15,750 $4,765 30.3%

About Dr. James Petre, MD

Dr. James Petre, MD is a Family Medicine healthcare provider based in East Moline, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619973989.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Petre, MD has received a total of $226,128 in payments from pharmaceutical and medical device companies, with $12,304 received in 2024. These payments were reported across 1,316 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($171,729).

As a Medicare-enrolled provider, Petre has provided services to 1,897 Medicare beneficiaries, totaling 3,001 services with total Medicare billing of $224,186. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location East Moline, IL
  • Active Since 06/22/2005
  • Last Updated 09/23/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1619973989

Products in Payments

  • FARXIGA (Drug) $57,651
  • Prolia (Biological) $37,286
  • PRALUENT ALIROCUMAB INJECTION (Biological) $32,802
  • INVOKANA (Drug) $19,458
  • EVENITY (Biological) $17,839
  • CONTRAVE (Drug) $16,547
  • QUVIVIQ (Drug) $13,307
  • PRALUENT (Drug) $5,705
  • NEXLIZET (Drug) $3,245
  • UBRELVY (Drug) $3,048
  • BYDUREON (Drug) $2,488
  • NEXLETOL (Drug) $2,126
  • JARDIANCE (Drug) $947.84
  • Ozempic (Drug) $677.38
  • Repatha (Biological) $647.74
  • QULIPTA (Drug) $474.45
  • VRAYLAR (Drug) $408.15
  • LINZESS (Drug) $383.05
  • ELIQUIS (Drug) $352.91
  • CHANTIX (Drug) $314.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in East Moline